TruScreen posts $3.5 million annual net loss

Wed, 29 May 2019

By Jenny Ruth May 30 (BusinessDesk) - Cervical cancer test maker TruScreen reported a $3.5 million net loss for the year ended March, failing to meet its June 2018 forecast that it would turn profitable. Now the company is saying it is making “positive commercial progress in its key markets and significant sales growth is expected.” The latest result compares with a $4.2 million net loss the previous year, with revenue up 43 percent at $3.1 million. After stripping out interest and R&D tax credits, revenue from sale of goods rose to $2...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Already a Subscriber ? Sign in here.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Health

Coke’s new cane-sweetened soda risks upending sugar supplies

The move is hardly an outlandish idea.

Bloomberg 5:00am

On the Money

On the Money: Butter, Meat, Water, and more

Pricey butter, quality meat, and some water, what more do you need in NZ?

Dileepa Fonseka 26 Jul 2025

On the Money: Butter, Meat, Water, and more

Markets

Eden Bradfield: The pros and cons of Sky’s big deal

You'd best hope streaming and advertising revenue make up for the $1 purchase.

Eden Bradfield 26 Jul 2025

Sponsored

Global real estate without the passport or paperwork

A global ETF offers access to income-generating real estate like data centres, healthcare and logistics warehouses – all in New Zealand dollars.

Blackrock, Smart Invest

Sponsored

‘Make Today the Day’: Why on-the-job training is the key to NZ’s service recovery

Covid gutted New Zealand’s service workforce. Training is the fix – and the future.

ServiceIQ

More Services

Services

Food Chain report shows $9m owing

More than $9.1m is owing in the liquidation of food supplier Food Chain, the first report in the insolvency shows. The company, which has ceased trading, had approximately 60 staff, and is also in receivership. The first liquidators' report of Adam Botterill and Damien Grant...

Staff reporters 11 Jul 2025